Überprüfung…
Automatisch übersetzt. Dosierung und Warnhinweise: bitte im englischen Original prüfen. Auf Englisch lesen
Homepage / Eingetragen in Nigeria / Cafergot Tablets

Cafergot Tablets

NAFDAC Reg.-Nr. 04-0461 Medikament

Registriert bei NAFDAC. Registrierung aktivAs of 31 October 2026 · synced automatically from official sources.
Produkt-
Cafergot Tablets
NAFDAC-Nummer
04-0461
Wirkstoff
Ergotamine; Caffeine
Stärke
1 mg; 100 mg
Form
Tablet
VPE:
1 x 20's (in amber glass bottle)
Hersteller
Not listed
Applicant (holder)
SEVEREIN PHARMACEUTICAL COMPANY LIMTED
Approved
28 Feb 2024
Status
Active View on NAFDAC ↗
Registration valid to
27 Feb 2029
WER WARNT
None found
Community reports
None
Times checked
0

About the medicine: Ergotamine: uses, dosage and brands worldwide

What we found

  • Cafergot Tablets is on the NAFDAC register with an active registration (04-0461). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.

How to use Cafergot Tablets

What the official label says. If a doctor prescribed it, follow the prescription. Your pack's leaflet comes first if it is different.

Serious warning: Serious and/or life-threatening peripheral ischemia has been associated with the coadministration of ergotamine tartrate and caffeine with potent CYP 3A4 inhibitors including protease inhibitors and macrolide antibiotics. Because CYP 3A4 inhibition elevates the serum levels of ergotamine tartrate and caffeine, the risk for vasospasm leading to cerebral ischemia and/or ischemia of the extremities is increased. Hence, concomitant use of these medications is contraindicated. …
Who it is for

Ergotamine Tartrate and Caffeine Indicated as therapy to abort or prevent vascular headache, e.g., migraine, migraine variants or so-called “histaminic cephalalgia”.

How to take it and how often
  • Procedure For best results, dosage should start at the first sign of an attack
  • Rectally Two suppositories is the maximum dose for an individual attack
  • Total weekly dosage should not exceed 5 suppositories
  • Ergotamine Tartrate and Caffeine Suppositories should not be used for chronic daily administration
  • In carefully selected patients, with due consideration of maximum dosage recommendations, administration of the drug at bedtime may be an appropriate short-term preventive measure
  • Maximum Adult Dosage: One suppository at start of attack; second suppository after 1 hour, if needed for full relief
  • Early administration gives maximum effectiveness
Talk to a doctor first if

Coadministration of ergotamine with potent CYP 3A4 inhibitors (ritonavir, nelfinavir, indinavir, erythromycin, clarithromycin, and troleandomycin) has been associated with acute ergot toxicity (ergotism) characterized by vasospasm and ischemia of the extremities (see PRECAUTIONS : Drug Interactions), with some cases resulting in amputation. …

Warnings

CYP 3A4 Inhibitors (e.g. Macrolide Antibiotics and Protease Inhibitors) Coadministration of ergotamine with potent CYP 3A4 inhibitors such as protease inhibitors or macrolide antibiotics has been associated with serious adverse events; for this reason, these drugs should not be given concomitantly with ergotamine (See CONTRAINDICATIONS ). While these reactions have not been reported with less potent CYP 3A4 inhibitors, there is a potential risk for serious toxicity including vasospasm when these drugs are used with ergotamine. …

Possible side effects

Cardiovascular: Vasoconstrictive complications of a serious nature may occur at times. These include ischemia, cyanosis, absence of pulse, cold extremities, gangrene, precordial distress and pain, EKG changes and muscle pains. Although these effects occur most commonly with long-term therapy at relatively high doses, they have also been reported with short-term or normal doses. Other cardiovascular adverse effects include transient tachycardia or bradycardia and hypertension. Gastrointestinal: Nausea and vomiting; rectal or anal ulcer (from overuse of suppositories). Neurological: Paresthesias, numbness, weakness, and vertigo. Allergic: Localized edema and itching. …

If you take too much

The toxic effects of an acute overdosage of ergotamine tartrate and caffeine are due primarily to the ergotamine component. The amount of caffeine is such that its toxic effects will be overshadowed by those of ergotamine. Symptoms include vomiting, numbness, tingling, pain and cyanosis of the extremities associated with diminished or absent peripheral pulses; hypertension or hypotension; drowsiness, stupor, coma, convulsions and shock. …

Dependence and misuse

There have been reports of drug abuse and psychological dependence in patients on ergotamine tartrate and caffeine therapy. Due to the chronicity of vascular headaches, it is imperative that patients be advised not to exceed recommended dosages with long-term use to avoid ergotism. (See PRECAUTIONS )

How to store it

Store and Dispense The suppositories should be refrigerated at 2° to 8°C (36° to 46°F). Distributed by: Cosette Pharmaceuticals, Inc. South Plainfield, NJ 07080 8-0166CPLNC1 Iss. 06/2020 VC7420

If you miss a dose

Take it when you remember, unless it is nearly time for the next dose. Then skip the missed one. Never take two doses at once to make up for it. Check your leaflet, as some medicines are different.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2022-11-29.

Label for ergotamine and caffeine, the active ingredient registered with NAFDAC.

Check your pack of Cafergot Tablets

Add the expiry date on your pack for a full Trust Score.

Or take photos of the pack
3 free checks left today Official sources: U.S. FDA · EMA (EU) · NAFDAC · WHO alerts

About Cafergot Tablets

What is in Cafergot Tablets?

Cafergot Tablets contains Ergotamine; Caffeine (1 mg; 100 mg), as tablet, according to its NAFDAC registration record.

Is Cafergot Tablets registered with NAFDAC?

Yes. Cafergot Tablets is listed on the NAFDAC register under registration number 04-0461, and its registration is active as of 31 October 2026.

Has Cafergot Tablets been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Cafergot Tablets in our automatically synced alert list.

How can I check that my pack of Cafergot Tablets is genuine?

Run a free authenticity scan with the NAFDAC number 04-0461, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

How do I take Cafergot Tablets?

Follow your prescription or the leaflet in your pack. The official label says: Procedure For best results, dosage should start at the first sign of an attack. Rectally Two suppositories is the maximum dose for an individual attack. Total weekly dosage should not exceed 5 suppositories. Ergotamine Tartrate and Caffeine Suppositories should not be used for chronic daily administration. In carefully selected patients, with due consideration of maximum dosage…

What is Cafergot Tablets used for?

Ergotamine Tartrate and Caffeine Indicated as therapy to abort or prevent vascular headache, e.g., migraine, migraine variants or so-called “histaminic cephalalgia”. (Summarised from the official U.S. FDA label for ergotamine and caffeine. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Cafergot Tablets? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.